Life Medical Research Group Corp
High Quality Clinical Research for a Healthier Life
Welcome to Life Medical Research Group Corp
Our focus is on advancing healthcare through innovative clinical trials that prioritize safety, quality, and an exceptional patient experience.
We strive for continuous improvement in every aspect of our work, ensuring that our research is grounded in evidence and built on trust.
Join us in our mission to improve health and enhance well-being through cutting-edge clinical research.
About Us
We are dedicated to advancing medical science and improving patient care through innovative clinical research. Our mission is to conduct high-quality studies that contribute to the development of new treatments and enhance healthcare outcomes.
Cutting-edge technological research
Why Choose Us
Expertise in Research
Our team comprises leading experts in clinical research, dedicated to advancing medical science. Our extensive knowledge and experience ensure that we conduct studies with precision, reliability, and integrity.
Rigorous Research Practices
We adhere to research protocols and quality standards. Every study we conduct is meticulously planned and executed, ensuring the highest level of safety and accuracy.
Uncompromising Quality and Safety
We prioritize health above all else. Our unwavering commitment to high-quality and safety standards guarantees that every aspect of our research is conducted with the utmost care and professionalism.
Know us
We are human, we are professionals.
We want you to know us and know that behind each of the investigations we carry out, there is a real person giving his best for the company.
NATIVE3:
NASH Trial
We are currently enrolling participants aged 18 and older for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY HISTOLOGY:
NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY OUTCOMES:
Compensated Cirrhosis due to NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on compensated cirrhosis due to Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH and compensated cirrhosis. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
Sjögren's Syndrome Trial
We are currently enrolling female participants from 18 to 75 years old for a Phase II clinical trial focused on Sjögren's syndrome. This study aims at improving moderate to severe symptoms of fatigue, dryness and/or pain related to this disease. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.